Jiangsu Nanfang Medical (603880) — Cash Flow-to-Debt Ratio
Jiangsu Nanfang Medical (603880) has a Cash Flow-to-Debt Ratio of 0.02x as of September 2025, meaning its operating cash flow of CN¥12.53 Million could theoretically repay 0% of its total liabilities (CN¥733.89 Million) in one year. Check how aggressively does Jiangsu Nanfang Medical reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Jiangsu Nanfang Medical Cash Flow-to-Debt Ratio (2012–2025)
Historical debt coverage capacity for Jiangsu Nanfang Medical across 14 annual periods. Also explore Jiangsu Nanfang Medical (603880) total assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Jiangsu Nanfang Medical (2012–2025)
Year-by-year debt coverage analysis for Jiangsu Nanfang Medical. For market capitalisation and broader financial context, see Jiangsu Nanfang Medical stock valuation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.06x | CN¥47.73 Million | CN¥746.77 Million | ▼ -22.1% |
| 2024 | 0.08x | CN¥63.32 Million | CN¥772.14 Million | ▲ +324.6% |
| 2023 | 0.02x | CN¥15.51 Million | CN¥803.11 Million | ▼ -48.4% |
| 2022 | 0.04x | CN¥31.28 Million | CN¥835.75 Million | ▲ +125.8% |
| 2021 | -0.15x | CN¥-84.25 Million | CN¥580.29 Million | ▼ -135.0% |
| 2020 | 0.41x | CN¥154.12 Million | CN¥371.84 Million | ▲ +279.5% |
| 2019 | 0.11x | CN¥32.99 Million | CN¥302.08 Million | ▼ -40.8% |
| 2018 | 0.18x | CN¥52.75 Million | CN¥285.78 Million | ▲ +7.0% |
| 2017 | 0.17x | CN¥49.24 Million | CN¥285.40 Million | ▼ -54.9% |
| 2016 | 0.38x | CN¥99.35 Million | CN¥259.87 Million | ▲ +5.8% |
| 2015 | 0.36x | CN¥90.66 Million | CN¥250.86 Million | ▲ +11.2% |
| 2014 | 0.33x | CN¥73.52 Million | CN¥226.10 Million | ▲ +230.6% |
| 2013 | 0.10x | CN¥20.14 Million | CN¥204.78 Million | ▼ -66.6% |
| 2012 | 0.29x | CN¥76.07 Million | CN¥258.41 Million | — |